A Review of Emerging ARNI Data in HFrEF

A Review of Emerging ARNI Data in HFrEF

These videos were funded by an unrestricted educational grant from Novartis.

The following videos are pending submission to the European Board for Accreditation in Cardiology (EBAC). Once accredited, the full programme will be available on www.radcliffeeducation.com

1. Review updated data of ARNI therapy for HFrEF present at the ESC 2019

2. Understand the current utilisation of ARNI therapy in HFrEF (guidelines and databases)

3. Interpret potential mechanistic data related to the clinical benefit of ARNI therapy including imaging and biomarker data

4. Apply new data covering the utilization of ARNI therapy in complex patients including recently decompensated and hospitalized patients.

5. Apply clinical and real-world evidence data for the treatment HFrEF with ARNI therapy.

 

 

Understanding the current utilization of ARNI therapy in HFrEF
ARIADNE in review
Uwe Zeymer, Klinikum Ludwigshafen, Ludwigshafen, DE
 
Watch Interview
Medtronic sponsored sessions at EHRA 2018 - Dr Jack McCready & Felicity Champney, RN

06.05 mins

 
Comment
Andrew Coats, University of Warwick, UK
Scott Solomon, Harvard University, MA, US
 
Watch Interview
Commentary on the ARIADNE trial-Prof Andrew Coats & Prof Scott Solomon

03.33 mins

 

Interpreting potential mechanistic data related to the clinical benefit of ARNI therapy including imaging and biomarker data
PROVE-HF in review
James Januzzi, Harvard Medical School, MA, US
 
Watch Interview
AF ablation efficiency and outcomes - Dr Aaisha Opel

06.57 mins

 
EVALUATE in review
Akshay Desai, Harvard Medical School, MA, US
 
Watch Interview
EVALUATE in review

08.22 mins

 
Comment
Andrew Coats, University of Warwick, UK
Scott Solomon, Harvard University, MA, US
 
Watch Interview
Commentary on the PROVE-HF and the EVALUATE-HF trials-Prof Andrew Coats & Prof Scott Solomon

06.20 mins

 

Applying new data covering the utilization of ARNI therapy in complex patients including recently decompensated and hospitalized patients
TRANSITION-CHF in review
Rolf Wachter, University of Leipzig, Leipzig, DE
 
Watch Interview
TRANSITION-CHF-In review-Prof Rolf Wachter

06.30 mins

 
PIONEER in review
David A Morrow, Harvard Medical School, MA, US
 
Watch Interview
PIONEER in review - Prof David A Morrow

05.40 mins

 
Comment
Andrew Coats, University of Warwick, UK
Scott Solomon, Harvard University, MA, US
 
Watch Interview
Commentary on the TRANSITION-CHF and the PIONEER trials-Prof Andrew Coats & Prof Scott Solomon

05.58 mins